½ÃÀ庸°í¼­
»óǰÄÚµå
1589509

¼¼°èÀÇ µðÁöÅРȣÈí±â ½ÃÀå : Á¦Ç°, ÀûÀÀ Áúȯ, À¯Åë ä³Î, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Digital Respiratory Devices Market by Product (Sensors & Apps, Smart Inhalers & Nebulizers), Disease Indications (Asthma, COPD, Infectious Diseases), Distribution Channel, End-Use - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 181 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

µðÁöÅРȣÈí±â ½ÃÀåÀº 2023³â¿¡ 234¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 306¾ï 1,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 30.95%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 1,548¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µðÁöÅРȣÈí±â ½ÃÀå¿¡´Â È£Èí±â ½Ã½ºÅÛÀÇ »óŸ¦ °ü¸®ÇÏ°í ¸ð´ÏÅ͸µÇϱâ À§ÇØ ¼³°èµÈ ±â¼ú Áß½ÉÀÇ ¼Ö·ç¼ÇÀÌ ±¤¹üÀ§ÇÏ°Ô Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. ¿¬°á¼º, ¼¾¼­ ¹× ºÐ¼®À» ÅëÇÕÇÏ¿© ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí, º¹¿ë ¾îµåÈ÷¾î·±½º¸¦ ³ôÀ̰í, °Ç°­ °ü¸® ÇÁ·Î¼¼½º¸¦ °£¼ÒÈ­ÇÕ´Ï´Ù. õ½Ä°ú COPD¿Í °°Àº È£Èí±â Áúȯ Áõ°¡¿Í ƯÈ÷ COVID-19ÀÇ ´ëÀ¯Çà¿¡ ÀÇÇØ °­Á¶µÇ´Â È¿°úÀûÀÎ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ Çʿ伺À¸·Î ÀÎÇØ ±× ¿ëµµ´Â °³ÀÎÀÇ °Ç°­ °ü¸®»Ó¸¸ ¾Æ´Ï¶ó ÀÓ»ó ȯ°æ°ú ¿¬±¸È¯°æ¿¡µµ Áø´Ü Á¤È®µµ¸¦ Çâ»ó½ÃÄÑ ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯¸¦ ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 234¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 306¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 1,548¾ï 7,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 30.95%

µðÁöÅРȣÈí±â ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â È£Èí±â ÁúȯÀÇ À¯º´·ü »ó½Â, °Ç°­ °ü¸® ÀåºñÀÇ ±â¼ú Áøº¸, ¿¹¹æ ÀÇ·á ´ëÃ¥¿¡ ´ëÇÑ ÁÖ¸ñ Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º È®´ë, ¿¹Ãø ºÐ¼®À» À§ÇÑ ÀΰøÁö´É°úÀÇ ÅëÇÕ, °³º°È­µÈ Åõ¾à °ü¸® ½Ã½ºÅÛ °³¹æ ±â¾÷ÀÌ ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ¸¦ °®°í ÀÖ´Ù´Â »ç½ÇÀÌ ¹àÇôÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº Àåºñ »óÈ£ ¿î¿ë¼ºÀ» °­È­ÇÏ°í °ß°íÇÑ »çÀ̹ö º¸¾È ´ëÃ¥À» È®º¸ÇÏ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀÎÅÍÆäÀ̽º·Î ȯÀÚ¸¦ Âü¿©µµ Çâ»ó¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù.

±×·¯³ª ½ÃÀå ¼ºÀåÀº ÀåºñÀÇ °íºñ¿ë, ±ÔÁ¦ ¹®Á¦, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á¿Í °°Àº Á¦¾à¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀû À庮¿¡¼­µµ º¹ÀâÇÑ ¹®Á¦°¡ ¹ß»ýÇÕ´Ï´Ù.ÀÌ ¹®Á¦¸¦ ÇØ°áÇÏ·Á¸é ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ, ±³À° ÀÌ´Ï¼ÅÆ¼ºê ¹× ±¹Á¦ ±ÔÁ¤À» Á¶Á¤ÇؾßÇÕ´Ï´Ù.

ŽÇè±â°¡ Àͼ÷ÇÑ Çõ½Å ºÐ¾ß¿¡¼­´Â È£Èí±â ÁúȯÀÇ Á¶±â Áø´ÜÀ» À§ÇÑ AI ±â¹Ý ¿¹Ãø ¸ðµ¨, º¸´Ù Á¤È®ÇÑ ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ´Â ¼¾¼­ ±â¼úÀÇ °­È­, Á¾ÇÕÀûÀÎ °Ç°­ ÀλçÀÌÆ®À» Á¦°øÇÏ´Â ÅëÇÕ ½Ã½ºÅÛ °³¹ß µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀåÀÌ ¹ßÀüÇÔ¿¡ µû¶ó °æÀïÀÇ º»ÁúÀº µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ Á¦°øµÇ´Â ÀλçÀÌÆ®ÀÇ Áú¿¡ ÁýÁßÇÒ °¡´É¼ºÀÌ ³ôÀ¸¸ç °æÀï·ÂÀ» À¯ÁöÇÏ°í »ç¾÷ ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇØ Áö¼ÓÀûÀÎ R&D ÅõÀÚ ÇÊ¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ : ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â µðÁöÅРȣÈí±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® ÇØ¸í

µðÁöÅРȣÈí±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ÀÌ´Â Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ¿í ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ È£Èí±â ÁúȯÀÇ À¯º´·üÀÇ »ó½Â
    • ÀÇ·á±â±âÀÇ µðÁöÅÐÈ­ÀÇ ÁøÀü
    • Åõ¾à °ü¸®¿Í Á÷Á¢ ÀÓ»ó ÄɾîÀÇ °³¼±¿¡ ÀÇÇÑ ¸Þ¸®Æ®
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • µðÁöÅРȣÈí±âÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • µðÁöÅРȣÈí±âÀÇ ±â¼ú ÅëÇÕ
    • »ç¾÷ È®´ë¸¦ À§ÇÑ ÅõÀÚ¿Í ÀÚ±Ý Á¶´Þ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á

Porter's Five Forces : µðÁöÅРȣÈí±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â µðÁöÅРȣÈí±â ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀïÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» ¼³¸íÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÇÇÒ ¼ö ÀÖÀ¸¸ç ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸Àå ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : µðÁöÅРȣÈí±â ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº µðÁöÅРȣÈí±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ °¡´ÉÇÕ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® µðÁöÅРȣÈí±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

µðÁöÅРȣÈí±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹à°Ô À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§ÇØ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º µðÁöÅРȣÈí±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â µðÁöÅРȣÈí±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ Çà·ÄÀ» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå µðÁöÅРȣÈí±â ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

µðÁöÅРȣÈí±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ È£Èí±â ÁúȯÀÇ ÀÌȯÀ²ÀÌ »ó½Â
      • ÀÇ·á±â±âÀÇ µðÁöÅÐÈ­ÀÇ ÁøÀü
      • Åõ¾à °ü¸®¿Í Á÷Á¢ÀûÀÎ ÀÓ»ó ÄɾîÀÇ °³¼±¿¡ ÀÇÇÑ ¸Þ¸®Æ®
    • ¾ïÁ¦¿äÀÎ
      • µðÁöÅРȣÈí±âÀÇ ºñ¿ëÀÌ ³ô´Ù
    • ±âȸ
      • µðÁöÅРȣÈí±âÀÇ ±â¼ú ÅëÇÕ
      • »ç¾÷ È®´ë¸¦ À§ÇÑ ÅõÀÚ¿Í ÀÚ±Ý Á¶´Þ Áõ°¡
    • °úÁ¦
      • º¸¾È ¹× ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå µðÁöÅРȣÈí±â ½ÃÀå : Á¦Ç°º°

  • ¼¾¼­¿Í ¾Û
  • ½º¸¶Æ® ÈíÀÔ±â¿Í ºÐ¹«±â

Á¦7Àå µðÁöÅРȣÈí±â ½ÃÀå Áúȯº°

  • õ½Ä
  • ¸¸¼º Æó»ö¼º ÆóÁúȯ
  • °¨¿°Áõ
  • ¼ö¸é½Ã ¹«È£ÈíÁõÈıº

Á¦8Àå µðÁöÅРȣÈí±â ½ÃÀå : À¯Åë ä³Îº°

  • º´¿ø ¾à±¹
  • ¿Â¶óÀÎ ¾à±¹
  • ¼Ò¸Å ¾à±¹

Á¦9Àå µðÁöÅРȣÈí±â ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ¿Ü·¡ Áø·á
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ µðÁöÅРȣÈí±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µðÁöÅРȣÈí±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µðÁöÅРȣÈí±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • Adherium Limited
  • AireHealth, LLC
  • Amiko Digital Health Limited
  • Aptar Pharma Company
  • BIOCORP Productio
  • Cognita Labs, LLC
  • Findair Sp. z oo
  • Infineon Technologies AG
  • Inspiro Medical Ltd. by OPKO Health, Inc.
  • Novartis AG
  • Pneuma Respiratory, Inc.
  • Propeller Health
  • Sensirion AG
  • Teva Pharmaceutical Industries Ltd.
BJH 24.11.21

The Digital Respiratory Devices Market was valued at USD 23.45 billion in 2023, expected to reach USD 30.61 billion in 2024, and is projected to grow at a CAGR of 30.95%, to USD 154.87 billion by 2030.

The market for digital respiratory devices encompasses a broad range of technology-driven solutions designed to manage and monitor respiratory conditions. These devices include digital inhalers, spirometers, and wearables, which integrate connectivity, sensors, and analytics to improve patient outcomes, enhance medication adherence, and streamline healthcare processes. The necessity for such devices arises from increasing incidences of respiratory diseases like asthma, COPD, and the need for effective remote patient monitoring solutions, particularly accentuated by the COVID-19 pandemic. Their applications span not only personal health management but extend into clinical environments and research settings, improving diagnostic accuracy and facilitating real-time data sharing. End-use sectors include hospitals, home care settings, and research institutes.

KEY MARKET STATISTICS
Base Year [2023] USD 23.45 billion
Estimated Year [2024] USD 30.61 billion
Forecast Year [2030] USD 154.87 billion
CAGR (%) 30.95%

Key growth factors influencing the digital respiratory device market include the rising prevalence of respiratory disorders, technological advancements in healthcare devices, and increased focus on preventive healthcare measures. Recent trends reveal potential opportunities in expanding telemedicine services, integration with artificial intelligence for predictive analytics, and developing personalized medication management systems. To capitalize on these opportunities, companies should focus on enhancing device interoperability, ensuring robust cybersecurity measures, and increasing patient engagement through user-friendly interfaces.

However, market growth faces limitations such as high costs of devices, regulatory challenges, and data privacy concerns. Complications also arise from a lack of awareness in emerging economies and potential technological barriers faced by older patient demographics. Addressing these challenges requires investment in cost-effective solutions, education initiatives, and international regulatory alignment.

Innovation areas ripe for exploration include AI-based predictive models for early diagnosis of respiratory conditions, enhanced sensor technologies that offer more accurate monitoring, and development of integrated systems that provide holistic health insights. As the market evolves, the nature of competition will likely focus on the quality of insights provided through data analytics, necessitating ongoing R&D investment to maintain a competitive edge and drive business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Digital Respiratory Devices Market

The Digital Respiratory Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of respiratory diseases worldwide
    • Increasing digitalization of medical devices
    • Benefits of improving medication management and direct clinical care
  • Market Restraints
    • High cost of digital respiratory devices
  • Market Opportunities
    • Technological integrations in digital respiratory devices
    • Rising investments and fundings for business expansion
  • Market Challenges
    • Security and privacy concerns

Porter's Five Forces: A Strategic Tool for Navigating the Digital Respiratory Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Digital Respiratory Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Digital Respiratory Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Digital Respiratory Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Digital Respiratory Devices Market

A detailed market share analysis in the Digital Respiratory Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Digital Respiratory Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Digital Respiratory Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Digital Respiratory Devices Market

A strategic analysis of the Digital Respiratory Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Digital Respiratory Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Adherium Limited, AireHealth, LLC, Amiko Digital Health Limited, Aptar Pharma Company, BIOCORP Productio, Cognita Labs, LLC, Findair Sp. z o. o., Infineon Technologies AG, Inspiro Medical Ltd. by OPKO Health, Inc., Novartis AG, Pneuma Respiratory, Inc., Propeller Health, Sensirion AG, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Digital Respiratory Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Sensors & Apps and Smart Inhalers & Nebulizers.
  • Based on Disease Indications, market is studied across Asthma, COPD, Infectious Diseases, and Sleep Apnea.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on End-Use, market is studied across Ambulatory Care, Homecare Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory diseases worldwide
      • 5.1.1.2. Increasing digitalization of medical devices
      • 5.1.1.3. Benefits of improving medication management and direct clinical care
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of digital respiratory devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological integrations in digital respiratory devices
      • 5.1.3.2. Rising investments and fundings for business expansion
    • 5.1.4. Challenges
      • 5.1.4.1. Security and privacy concerns
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Digital Respiratory Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Sensors & Apps
  • 6.3. Smart Inhalers & Nebulizers

7. Digital Respiratory Devices Market, by Disease Indications

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD
  • 7.4. Infectious Diseases
  • 7.5. Sleep Apnea

8. Digital Respiratory Devices Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Digital Respiratory Devices Market, by End-Use

  • 9.1. Introduction
  • 9.2. Ambulatory Care
  • 9.3. Homecare Settings
  • 9.4. Hospitals

10. Americas Digital Respiratory Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Digital Respiratory Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Digital Respiratory Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Adherium Limited
  • 3. AireHealth, LLC
  • 4. Amiko Digital Health Limited
  • 5. Aptar Pharma Company
  • 6. BIOCORP Productio
  • 7. Cognita Labs, LLC
  • 8. Findair Sp. z o. o.
  • 9. Infineon Technologies AG
  • 10. Inspiro Medical Ltd. by OPKO Health, Inc.
  • 11. Novartis AG
  • 12. Pneuma Respiratory, Inc.
  • 13. Propeller Health
  • 14. Sensirion AG
  • 15. Teva Pharmaceutical Industries Ltd.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦